Stojanović, M., & Bursać, D. (2024). Immunotoxicity of Pembrolizumab in patients with metastatic non-small cell lung cancer: A single-centre study. Archive of Oncology, 30(1), 14-18. https://doi.org/10.2298/AOO240304006S